Ana López-Pérez

Ana López-Pérez

Auto-generated profile, based on publicly available information

Ana López-Pérez

Hematology and Oncology Program, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LSLaura Sudupe
Laura Sudupe
ELEMMA MUINOS LOPEZ
EMMA MUINOS LOPEZ
ALAna Rosa Lopez-Perez
Ana Rosa Lopez-Perez
AVAmaia Vilas-Zornoza
Amaia Vilas-Zornoza
SSSarai Sarvide
Sarai Sarvide
FPFelipe Prosper
Felipe Prosper
The bone marrow (BM) is a complex tissue where spatial relationships influence cell behavior, signaling, and function. Consequently, understanding the whole dynamics of cellular interactions requires complementary spatial techniques that preserve and map the architecture of cell populations in situ . We successfully conducted spatial transcriptional profiling using Visium Spatial Gene Expression in formalin-fixed paraffin-embedded (FFPE) BM samples obtained from healthy and Multiple Myeloma (MM) mouse models and patients, addressing the technical challenges of applying spatial technology to long bone samples. A custom data-analysis framework that combines spatial with single-cell transcriptomic profiles identified both the BM cellular composition and the existing cell relations. This allowed us to visualize the spatial distribution of transcriptionally heterogeneous MM plasma cells (MM-PC). We spatially delineated transcriptional programs associated with MM, including NETosis and IL-17-driven inflammatory signaling, which were inversely correlated to malignant PC-enriched regions. Furthermore, a gradient of MM-PC density spatially correlated with a shift from effector-to-exhausted T cell phenotypes. The translational relevance of our findings was confirmed using FFPE BM biopsies from MM patients with varying levels of malignant PC infiltration. In summary, we provide the first spatial transcriptomics analysis applied to a mouse and human mineralized bone tissue and illustrate the BM cellular architecture of MM, revealing deregulated mechanisms underlying MM intercellular communication.

13 January 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
SHSilvia C. Hernández
Silvia C. Hernández
MAMarina Ainciburu
Marina Ainciburu
LSLaura Sudupe
Laura Sudupe
NPNuria Planell
Nuria Planell
MLMaría López-Moreno
María López-Moreno
DGDavid Gomez-Cabrero
David Gomez-Cabrero
Cardiac fibroblasts (CFs) are key mediators of heart repair following myocardial infarction (MI). A specific CF subpopulation, termed Reparative Cardiac Fibroblasts (RCFs), has been shown to orchestrate scar formation and prevent ventricular rupture after MI. However, the timing of RCF appearance and the molecular events underlying this transition remain largely undefined. Here, we present a multi-modal dataset capturing the transcriptional dynamics of CFs during the early phase post-MI. Our integrative dataset combines bulk RNA sequencing, RNAscope in situ hybridization, and spatial transcriptomics to anatomically and temporally map the gene expression changes associated with the transition into RCFs. The dataset provides resources to characterize the distinct molecular programs that guide the emergence of RCFs from Periostin ( Postn ) + activated CFs. This dataset provides a valuable resource for investigating CF heterogeneity and reparative pathways following MI. All raw and processed data, along with detailed metadata and annotations, are made available to facilitate reuse by the cardiovascular and single-cell biology communities.

5 August 2026 in Bone Research
Verified
Journal Article
Open access
PDF file
MAMahtab Avijgan
Mahtab Avijgan
ALAna R. López-Pérez
Ana R. López-Pérez
LGLeire Alonso Galicia
Leire Alonso Galicia
JMJose G. Marchan-Alvarez
Jose G. Marchan-Alvarez
LSLaura Sudupe
Laura Sudupe
PNPhillip Newton
Phillip Newton
Maintaining postnatal bone growth is crucial for humans to reach their final height. To determine transcriptional networks coordinating this process, we applied spatially resolved transcriptomics to growth plate biopsies obtained from healthy adolescents who underwent epiphysiodesis surgery for idiopathic tall stature. Spatial profiling revealed new markers for each zone of the human growth plate and identified genes associated with poorly understood growth disorders, including the novel hypertrophic zone marker SGMS2. We elaborated on this finding and established that Sgms2 is present in growth plate-derived matrix vesicles, and its activity facilitates mineralization - a process impaired in patients with SGMS2 mutations. By exploring the low transcriptional activity of resting zone chondrocytes, we found that a subset of these cells exists in a functionally quiescent state in vivo, as determined by their predominantly nuclear mRNA, abundant heterochromatin, and ability to exit the G0 phase under specific conditions - features shared with skeletal stem cells in mouse growth plates. Additionally, we identified distinct sub-populations of human resting zone chondrocytes; an exploration of their hierarchy determined that CHRDL2 and/or SFRP5-positive sub-populations were among the least quiescent resting zone cells. In summary, we generated a comprehensive map of gene expression within the human growth plate, revealing novel zone-specific markers, new primary growth disorders, candidate pharmacological targets, and sub-populations of resting zone chondrocytes with features of quiescent stem cells. These results contribute to a better understanding of the cellular and molecular mechanisms governing human height and can facilitate improved diagnosis and treatment strategies for patients with skeletal growth disorders.

9 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAna López-Pérez
Ana López-Pérez
Silvia RemeseiroSilvia Remeseiro
Silvia Remeseiro
AHAndreas Hörnblad
Andreas Hörnblad
Background & Aims: This study aimed to provide a comprehensive understanding of the regulatory and transcriptional landscape in liver tumours from DIAMOND mice, a mouse model that mimics human hepatocellular carcinoma (HCC) in the context of metabolic associated fatty liver disease (MAFLD). Methods: RNA-sequencing and ChIP-sequencing were used to study the gene expression and regulatory changes in DIAMOND liver tumours. RNA in situ hybridisation splice variant analysis was used to study β-catenin exon 3 exclusion in tumours at cellular resolution. Sequencing data on β-catenin exon 3 splicing in DIAMOND tumours was compared to data from human patients and cell lines. Results: The study found an increase in Wnt/β-catenin-signalling accompanied by rewiring of the Wnt/β-catenin regulatory network in DIAMOND tumours. Changes include switching in the expression of the canonical TCF/LEF downstream effectors and associated chromatin remodelling. In addition, a large subset of DIAMOND tumours showed aberrant splicing of β-catenin, which generate an mRNA isoform that encodes an oncogenic protein. Similar splicing events were found in a fraction of human HCC and hepatoblastoma samples. Conclusions: This study provides evidence that western diet induces aberrant genome-wide splicing in DIAMOND livers, and in particular of the β-catenin gene in a subset of DIAMOND liver tumours. This mechanism is distinct from previously reported activation of β-catenin in HCC and mouse models, since it is independent on mutations in the locus. Our data suggests that metabolic input modulates gene regulatory network responses to active Wnt-signalling, which will be an important consideration also in the human setting. Lay summary: Sequencing data generated in this study highlights the effect of diet in modulating oncogenic gene expression and underscores an alternative mutation-independent mechanism leading to constitutive activation of β-catenin, a well-known driver of liver cancer.

13 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EHEmanuel Holm
Emanuel Holm
IVIsabeau Vermeulen
Isabeau Vermeulen
SPSaba Parween
Saba Parween
ALAna López-Pérez
Ana López-Pérez
BCBerta Cillero-Pastor
Berta Cillero-Pastor
AHAndreas Hörnblad
Andreas Hörnblad
: Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common chronic liver disease worldwide for which there are no approved treatments. Adenosine monophosphate-activated protein kinase (AMPK) is an interesting therapeutical target since it acts as a central regulator of cellular metabolism. Despite efforts to target the AMPK, no direct activators has yet been approved for treatment of this disease. This study investigates the effect of AMPK activator ATX-304 in a preclinical mouse model of progressive fatty liver disease. The data demonstrate that ATX-304 diminishes body fat mass, lowers blood cholesterol levels, mitigates liver steatosis, and ameliorates the development of liver fibrosis. The beneficial effects of ATX-304 treatment are accompanied by a shift in the liver metabolic program, including increased lipid oxidation, reduced lipid synthesis, as well as remodeling of cholesterol and lipid transport. We also observed variations in lipid distribution among liver lobes in response to ATX-304, and a shift in the zonal distribution of lipid droplets upon treatment. Taken together, our data suggest that ATX-304 holds promise as a potential treatment for Metabolically Associated Fatty Liver Disease (MAFLD), including in human patients.

9 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAna R. López-Pérez
Ana R. López-Pérez
PBPiotr J. Balwierz
Piotr J. Balwierz
BLBoris Lenhard
Boris Lenhard
FMFerenc Muller
Ferenc Muller
FWFiona C. Wardle
Fiona C. Wardle
BPBernard Peers
Bernard Peers
Retinoic acid (RA) is a key signal for the specification of the pancreas. Still, the gene regulatory cascade triggered by RA in the endoderm remains poorly characterized. In this study, we investigated this regulatory network in zebrafish by combining RNA-seq, RAR ChIP-seq and ATAC-seq assays. By analysing the effect of RA and of the RA receptor (RAR) antagonist BMS439 on the transcriptome and on the chromatin accessibility of endodermal cells, we identified a large set of genes and regulatory regions regulated by RA signalling. RAR ChIP-seq further defined the direct RAR target genes including the known hox genes as well as several pancreatic regulators like mnx1, insm1b, hnf1ba and gata6 . Comparison of our zebrafish data with available murine RAR ChIP-seq data highlighted conserved direct target genes and revealed that some RAR sites are under strong evolutionary constraints. Among them, a novel highly conserved RAR-induced enhancer was identified downstream of the HoxB locus and driving expression in the nervous system and in the gut in a RA-dependant manner. Finally, ATAC-seq data unveiled the role of the RAR-direct targets Hnf1ba and Gata6 in opening chromatin at many regulatory loci upon RA treatment. Summary statement: Combination of RNA-seq, ChIP-seq and ATAC-seq assays identifies genes directly and indirectly regulated by RA signalling in zebrafish endoderm. Comparison with murine data highlights RAR binding sites conserved among vertebrates.